Capital Fund Management S.A. Axsome Therapeutics, Inc. Call Options Transaction History

Capital Fund Management S.A.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $619,146 - $957,709	10,600 New	10,600 $761,000
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $779,076 - $978,576	-11,400 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$49.87 - $98.69 $568,518 - $1.13 Million	11,400 New	11,400 $937,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.74B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.